Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Modesto. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Modesto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
EYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201. All participants in the study will receive a total of 3 injections of EYE201 into the study eye, spaced at 4 weeks apart. In the first part, termed the multiple ascending dose (MAD) portion of study, the safety of EYE201 will be assessed at increasing doses in branch retinal vein occlusion (BRVO) participants. Approximately 12 participants will be entered in this part of the s
Sponsor: EyeBiotech Ltd.
Check if you qualify for this macular degeneration clinical trial in Modesto, CA
If you're searching for macular degeneration treatment options in Modesto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Modesto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.